[The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland]

Med Radiol (Mosk). 1989 Oct;34(10):31-4.
[Article in Russian]

Abstract

The materials of observation over 231 patients with highly differentiated thyroid cancer were used to define indications for 131I-therapy, to specify course and summary doses taking into account side-effects of 131I. 131I-therapy is an effective method in multimodality therapy of highly differentiated thyroid cancer.

Publication types

  • English Abstract

MeSH terms

  • Adenocarcinoma / radiotherapy
  • Adenocarcinoma / surgery
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Papillary / radiotherapy
  • Carcinoma, Papillary / surgery
  • Child
  • Combined Modality Therapy
  • Female
  • Humans
  • Iodine Radioisotopes / therapeutic use*
  • Male
  • Middle Aged
  • Thyroid Neoplasms / radiotherapy*
  • Thyroid Neoplasms / surgery
  • Thyroidectomy

Substances

  • Iodine Radioisotopes